Search results
Results From The WOW.Com Content Network
[29] [30] Furthermore, THC is shown to have a quicker development of tolerance to sleep-inducing effects. [31] It is worth noting that synthetic THC has also shown the same effects of developed tolerance to sleep latency effects. [32] However, individuals diagnosed with high PTSD scores have endorsed the use of medical cannabis for sleeping.
Synthetic cannabinoids have also been used recreationally because they are inexpensive and are typically not revealed by the standard marijuana drug tests. [55] Unlike nabilone, the synthetic cannabinoids found being used for recreational use did not have any documented therapeutic effects. [38]
When usual treatments are ineffective, cannabinoids have also been recommended for anorexia, arthritis, glaucoma, [19] and migraine. [20] It is unclear whether American states might be able to mitigate the adverse effects of the opioid epidemic by prescribing medical cannabis as an alternative pain management drug. [21]
An independent panel for the Food and Drug Administration (FDA) has rejected the use of MDMA as a form of therapy for posttraumatic stress disorder (PTSD). MDMA, which is also known as ecstasy, is ...
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
In 1978, he and David E. Nichols published a report on the drug's psychoactive effect in humans. [227] They described MDMA as inducing "an easily controlled altered state of consciousness with emotional and sensual overtones" comparable "to marijuana, to psilocybin devoid of the hallucinatory component, or to low levels of MDA". [245]
Psychotherapy is an effective treatment for trauma-related disorders. A meta-analysis of treatment outcomes has shown that 67% of patients who completed treatment for PTSD no longer met diagnostic criteria for PTSD. [4] For those seeking evidence-based psychotherapy treatment, it is estimated that 22-24% will drop out of their treatment.
Hexahydrocannabinol (HHC) is a hydrogenated derivative of tetrahydrocannabinol (THC). It is a naturally occurring phytocannabinoid that has rarely been identified as a trace component in Cannabis sativa, [1] [2] but can also be produced synthetically by firstly acid cyclization of cannabidiol and then hydrogenation of tetrahydrocannabinol.